➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Colorcon
Baxter
Boehringer Ingelheim
AstraZeneca

Last Updated: August 3, 2021

DrugPatentWatch Database Preview

Glyburide - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing

« Back to Dashboard

What are the generic drug sources for glyburide and what is the scope of patent protection?

Glyburide is the generic ingredient in seven branded drugs marketed by Sanofi Aventis Us, Actavis Elizabeth, Aurobindo Pharma, Cadila Pharms Ltd, Epic Pharma Llc, Heritage Pharms Inc, Impax Labs Inc, Orient Pharma Co Ltd, Swiss Pharm, Teva, Zydus Pharms, Dava Pharms Inc, Hikma, Mylan, Yaopharma Co Ltd, Pfizer, and Bristol Myers Squibb, and is included in twenty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty drug master file entries for glyburide. Twenty-six suppliers are listed for this compound.

Drug Prices for glyburide

See drug prices for glyburide

Drug Sales Revenue Trends for glyburide

See drug sales revenues for glyburide

Recent Clinical Trials for glyburide

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Ironwood Pharmaceuticals, Inc.Phase 1
Medical College of WisconsinPhase 4
The University of Texas Health Science Center, HoustonPhase 4

See all glyburide clinical trials

Pharmacology for glyburide
Drug ClassSulfonylurea
Medical Subject Heading (MeSH) Categories for glyburide
Paragraph IV (Patent) Challenges for GLYBURIDE
Tradename Dosage Ingredient NDA Submissiondate
GLYNASE TABLET;ORAL glyburide 020051

US Patents and Regulatory Information for glyburide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Zydus Pharms GLYBURIDE glyburide TABLET;ORAL 206749-001 May 10, 2016 AB1 RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Swiss Pharm GLYBURIDE glyburide TABLET;ORAL 203581-002 Apr 14, 2016 AB1 RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Zydus Pharms GLYBURIDE AND METFORMIN HYDROCHLORIDE glyburide; metformin hydrochloride TABLET;ORAL 206748-002 Feb 29, 2016 AB RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-003 Sep 24, 1993 DISCN Yes No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Orient Pharma Co Ltd GLYBURIDE glyburide TABLET;ORAL 206483-001 Feb 22, 2019 AB1 RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Heritage Pharms Inc GLYBURIDE glyburide TABLET;ORAL 090937-003 Feb 28, 2011 AB1 RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
Heritage Pharms Inc GLYBURIDE glyburide TABLET;ORAL 090937-002 Feb 28, 2011 AB1 RX No No ⤷  Try it Free ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for glyburide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Pfizer GLYNASE glyburide TABLET;ORAL 020051-001 Mar 4, 1992 ⤷  Try it Free ⤷  Try it Free
Pfizer MICRONASE glyburide TABLET;ORAL 017498-001 May 1, 1984 ⤷  Try it Free ⤷  Try it Free
Sanofi Aventis Us DIABETA glyburide TABLET;ORAL 017532-002 May 1, 1984 ⤷  Try it Free ⤷  Try it Free
Pfizer MICRONASE glyburide TABLET;ORAL 017498-003 May 1, 1984 ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-002 Mar 4, 1992 ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-003 Sep 24, 1993 ⤷  Try it Free ⤷  Try it Free
Pfizer GLYNASE glyburide TABLET;ORAL 020051-002 Mar 4, 1992 ⤷  Try it Free ⤷  Try it Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson
Colorcon
Baxter
Boehringer Ingelheim
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.